Display options
Cite
Celebi AR, Kadayifcilar S, Eldem B. Hyperbaric oxygen therapy in branch retinal artery occlusion in a 15-year-old boy with methylenetetrahydrofolate reductase mutation. Case Rep Ophthalmol Med. 2015;2015:640247doi: 10.1155/2015/640247.
Celebi, A. R., Kadayifcilar, S., & Eldem, B. (2015). Hyperbaric oxygen therapy in branch retinal artery occlusion in a 15-year-old boy with methylenetetrahydrofolate reductase mutation. Case reports in ophthalmological medicine, 2015640247. https://doi.org/10.1155/2015/640247
Celebi, Ali Riza Cenk, et al. "Hyperbaric oxygen therapy in branch retinal artery occlusion in a 15-year-old boy with methylenetetrahydrofolate reductase mutation." Case reports in ophthalmological medicine vol. 2015 (2015): 640247. doi: https://doi.org/10.1155/2015/640247
Celebi AR, Kadayifcilar S, Eldem B. Hyperbaric oxygen therapy in branch retinal artery occlusion in a 15-year-old boy with methylenetetrahydrofolate reductase mutation. Case Rep Ophthalmol Med. 2015;2015:640247. doi: 10.1155/2015/640247. Epub 2015 Feb 05. PMID: 25722905; PMCID: PMC4334424.
Copy Download .nbib Format: NLM
Share it on

Case Rep Ophthalmol Med. 2015;2015:640247. doi: 10.1155/2015/640247. Epub 2015 Feb 05.

Hyperbaric oxygen therapy in branch retinal artery occlusion in a 15-year-old boy with methylenetetrahydrofolate reductase mutation.

Case reports in ophthalmological medicine

Ali Riza Cenk Celebi, Sibel Kadayifcilar, Bora Eldem

Affiliations

  1. Department of Ophthalmology, Acibadem University School of Medicine, 34303 Istanbul, Turkey.
  2. Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey.

PMID: 25722905 PMCID: PMC4334424 DOI: 10.1155/2015/640247

Abstract

Purpose. To report the efficacy of hyperbaric oxygen (HBO) therapy in a case of branch retinal artery occlusion (BRAO) in a 15-year-old boy. Methods. We report a 15-year-old boy with sudden loss of vision due to BRAO. Examination included laboratory evaluation for systemic risk factors. Follow-up exams included visual acuity, fundus examination, fundus fluorescein angiography, and visual field testing. HBO therapy was employed for treatment. Results. Medical history was positive for isolated glucocorticoid deficiency. Laboratory evaluation disclosed hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) mutation. The visual acuity 0.05 at presentation improved to 0.8 after 20 days of HBO therapy. There was no change on visual fields. Conclusion. In this pediatric case, HBO therapy was useful in the treatment of BRAO.

References

  1. Surv Ophthalmol. 2008 Mar-Apr;53(2):112-20 - PubMed
  2. Indian J Ophthalmol. 2012 Mar-Apr;60(2):95-100 - PubMed
  3. Pediatrics. 1998 Nov;102(5):E53 - PubMed
  4. Am J Ophthalmol. 2002 Jul;134(1):57-61 - PubMed
  5. Am J Ophthalmol. 1993 Feb 15;115(2):162-7 - PubMed
  6. Am J Hum Genet. 1996 Jul;59(1):262-4 - PubMed
  7. Undersea Hyperb Med. 2012 Sep-Oct;39(5):943-53 - PubMed
  8. Am J Ophthalmol. 1995 Dec;120(6):776-83 - PubMed
  9. J Nutr. 1996 Apr;126(4 Suppl):1276S-80S - PubMed

Publication Types